Government's emphasis on 'Housing for All by 2022', RERA and infrastructure status to reality sector provided the required revival to the reality ... and Visa norms in the US put weight on IT companies, while, slow approvals by USFDA and pricing pressure kept the Indian pharma companies underneath.
Read more: Why should investors lower their expectation from market in 2018?